Promoter holding
64.27%
PD
Pathkind Diagnostics Private Limited - Due diligence report
A 360° intelligence report on Pathkind Labs: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Pathkind Labs — 360° Intelligence Report
Generated from MCA filings & public records69/100
Trust Score
Moderate
Pathkind Labs is assessed as Moderate with a Trust Score of 69/100. Pathkind Labs is an active private limited indian non-government company incorporated in 2016, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 30 Jun 2026 from the latest processed filings. Pathkind Diagnostics Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
69/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 68/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: Bhagi Bhardwaj Gaur & Co. on 2023-09-15.
- Delayed payments to MSME suppliers disclosed (284 disclosure(s)).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SURENDRA LUNIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHEETAL ARORA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARJUN JUNEJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ROHIT BRIJMOHAN MANTRI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| EKLAVYA JUNEJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJEEV JUNEJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHIBU SHRESTHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJEEV VASHISHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJEEV VASHISHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 9 directors on the board.
- SANJEEV VASHISHTA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
82 allotment(s) · 8 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: EKLAVYA JUNEJA (Whole-time director) · SANJEEV VASHISHTA (Managing Director) · SANJEEV VASHISHTA (CEO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 9 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 94.89 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment65/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Aug 2023
Director appointed
SHIBU SHRESTHA (Company Secretary)
07 Jul 2023
Director ceased
PRABHAT SINGH
31 Mar 2023
Share transfer (FY 2023)
143469.00000000 shares to Pathkind Diagnostics Private Limited Emloyee Welfare Trust
Share transfer (FY 2023)
85471.00000000 shares to Pathkind Diagnostics Private Limited Emloyee Welfare Trust
Share transfer (FY 2023)
76312.00000000 shares to Pathkind Diagnostics Private Limited Emloyee Welfare Trust
01 Jul 2022
Director ceased
EKLAVYA JUNEJA
26 May 2022
Securities allotted
1526261 Preference Shares - 175.00 cr raised
Director appointed
ROHIT BRIJMOHAN MANTRI (Nominee Director)
Director ceased
ROHIT BRIJMOHAN MANTRI
31 Mar 2022
Share transfer (FY 2022)
1249135.00000000 shares to Ramesh Juneja
Share transfer (FY 2022)
1249135.00000000 shares to Rajeev Juneja
23 Mar 2022
Securities allotted
2551055 Equity Shares - 2.55 cr raised
21 Feb 2022
Securities allotted
540574 Equity Shares - 54.06 Lakh raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
9 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 82 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Dentzz Dental Care Centres | U85190MH2005PTC153435 | Mumbai, Maharashtra, India |
| Ampath | U93000TG2007PTC056136 | Hyderabad, Telangana, India |
| Chandan Healthcare | L85110UP2003PLC193493 | Lucknow, Uttar Pradesh, India |
| Suburban Diagnostics | U85110MH2002PTC136144 | Mumbai, Maharashtra, India |
| Aoi | U85110TG2006PTC051690 | Hyderabad, Telangana, India |
| Medplus | L85110TG2006PLC051845 | Hyderabad, Telangana, India |
| Dr Lal Pathlabs | L74899DL1995PLC065388 | New Delhi, Delhi, India |
| Rellife | U24239MH2001PTC130654 | Navi Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Pathkind Labs before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Pathkind Labs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Pathkind Labs - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 69/100, distress signals and MSME payment-delay disclosures - know whether Pathkind Labs pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Pathkind Labs - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Pathkind Labs an active company?
Pathkind Labs has MCA status “Active” with a compliance score of 68/100 (Moderate).
Is Pathkind Labs financially healthy?
Pathkind Labs has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Pathkind Labs?
Its overall Trust Score is 69/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Pathkind Labs?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 9 active director(s) are on record.
Does Pathkind Labs have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Pathkind Labs up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 68/100 (Moderate).
Is it risky to lend to Pathkind Labs?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
